Why the study?
What are the frequency-dependent electrophysiological effects of flecainide, nifekalant, and d,l-sotalol on the human atrium?
What are the frequency-dependent electrophysiological effects of flecainide, nifekalant, and d,l-sotalol on the human atrium?
Class Ic agents like flecainide exhibit use-dependent electrophysiological effects that may favor atrial fibrillation termination, while class III agents show reverse use-dependence that may favor prevention.
May guide rate-specific antiarrhythmic selection in AF; hypothesis-generating for human atrial electrophysiology.
To compare the effects of class Ic and III antiarrhythmic agents on the termination and prevention of atrial fibrillation, the present study investigated the use-dependent electrophysiological effects of flecainide, nifekalant and d,l-sotalol on the human atrium. Flecainide significantly prolonged effective refractory period (ERP), intra-atrial conduction time (IACT) and monophasic action potential duration (MAPD), and its effects on ERP and IACT were use-dependent. Nifekalalant significantly prolonged ERP and MAPD, and these effects were reverse use-dependent; however, there was no significant change in IACT. d,l-Sotalol significantly prolonged MAPD and the effect was reverse use-dependent. It significantly prolonged ERP, but the effect was not reverse use-dependent. d,l-Sotalol increased IACT in a use-dependent manner. Thus, for atrial fibrillation, class Ic antiarrhythmic agents might be more effective in termination and class III antiarrhythmic agents might be more effective in prevention.
No takes yet. Share an insight, caveat, or question.
Watanabe et al. (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: